203 related articles for article (PubMed ID: 9973947)
1. Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q.
Ishida F; Shimodaira S; Kobayashi H; Saito H; Kaku M; Kanzaki A; Yawata Y; Kitano K; Kiyosawa K
Cancer Genet Cytogenet; 1999 Jan; 108(2):162-5. PubMed ID: 9973947
[TBL] [Abstract][Full Text] [Related]
2. Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome.
Hur M; Lee KM; Cho HC; Park YI; Kim SH; Chang YW; Kim YR; Cho HI
Clin Lab Haematol; 2004 Feb; 26(1):69-72. PubMed ID: 14738441
[TBL] [Abstract][Full Text] [Related]
3. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
4. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
[TBL] [Abstract][Full Text] [Related]
5. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of centromeric fusion in 7p/1q translocation associated with myelodysplastic syndrome.
Hoo JJ; Szego K; Jones B
Cancer Genet Cytogenet; 1992 Dec; 64(2):186-8. PubMed ID: 1486571
[TBL] [Abstract][Full Text] [Related]
7. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q).
Wu C; Zhang J; Bai S; Yao J; Qiu H; Xue Y; Chen S; Wu Y; Shen J; Pan J
Cancer Genet; 2016 Oct; 209(10):456-462. PubMed ID: 27810074
[TBL] [Abstract][Full Text] [Related]
9. Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10).
Manabe M; Hagiwara Y; Asada R; Tanizawa N; Nanno S; Koh KR
Br J Haematol; 2022 Jan; 196(1):7. PubMed ID: 34322868
[No Abstract] [Full Text] [Related]
10. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome of del 20q with plasma cell dysplasia.
Saito N; Higashiura K; Ehata K; Kurosawa S; Honma K; Abe M; Kimura A; Suzuki M; Nakamura S; Shiku H; Kean Ooi H
J Clin Exp Hematop; 2011; 51(2):141-5. PubMed ID: 22104314
[TBL] [Abstract][Full Text] [Related]
12. A der(13)t(7;13)(p13;q14) with monoallelic loss of RB1 and D13S319 in myelodysplastic syndrome.
Yamamoto K; Ito M; Minagawa K; Urahama N; Sada A; Okamura A; Matsui T
Cancer Genet Cytogenet; 2005 Oct; 162(2):160-5. PubMed ID: 16213365
[TBL] [Abstract][Full Text] [Related]
13. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and cytogenetic study of 6 cases of hematological disorders associated with 20q- and t (20;21) (q11;q11) abnormalities].
Wu CX; Pan JL; Qiu HY; Xue YQ; Chen SN; Zhang J; Wu YF; Shen J; Bai SX; Wang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):138-42. PubMed ID: 23568721
[TBL] [Abstract][Full Text] [Related]
15. Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.
Yamamoto K; Nagata K; Yagasaki F; Tsurukubo Y; Tamura A; Taniwaki M; Hamaguchi H
Cancer Genet Cytogenet; 2000 Jun; 119(2):113-7. PubMed ID: 10867145
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.
Sun J; Yin CC; Cui W; Chen SS; Medeiros LJ; Lu G
Am J Clin Pathol; 2011 Mar; 135(3):391-7. PubMed ID: 21350093
[TBL] [Abstract][Full Text] [Related]
17. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
[TBL] [Abstract][Full Text] [Related]
18. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
Li T; Xue Y; Wu Y; Pan J
Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of bone marrow cell morphology in a cohort of patients with isolated idic(20q-) karyotypic abnormalities.
Liu D; Pan J; Wu C; Liang J; Wang J; Chen S; Chen Z
Ann Hematol; 2019 Mar; 98(3):605-614. PubMed ID: 30483862
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
